Cytological and architectural heterogeneity in ductal carcinoma in situ of the breast

Journal of Clinical Pathology

Volumn 50, Issue 7, 1997, Pages 596-599

  Quinn, Cecily M ^a   Ostrowski, Julian L ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Architectural patterns; Cytological grade; Ductal carcinoma in situ

Indexed keywords

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; CANCER CYTODIAGNOSIS; CANCER GRADING; CARCINOMA IN SITU; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TISSUE NECROSIS;

EID: 0030798069     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.50.7.596     Document Type: Article

References (22)

1. Lagios MD, Margolin FR, Westdahl PR, Rose ME. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989;63:618-24.
2. Lagios MD. Duct carcinoma in situ. Pathology and treatment. Surg Clin North Am 1990;70:853-71.
3. Locker AP, Horrocks C, Gilmour AS, Ellis IO, Dowle CS, Elston CW, et al. Flow cytometric and histologic analysis of ductal carcinoma in situ of the breast. Br J Surg 1990;77:564-7.
4. Killeen JL, Namiki H. DNA analysis of ductal carcinoma in situ of the breast. A comparison with histological features. Cancer 1991;68:2602-7.
5. Barnes DM, Meyer JS, Gonzalez JG, Gullick WJ, Millis RR. Relationship between c-erbB-2 immunoreactivity and thymidine labelling index in breast carcinoma in situ. Breast Cancer Res Treat 1991;18:11-17.
6. van Dongen JA, Holland R, Peterse JL, Fentiman IS, Lagios MD, Millis RR, et al. Ductal carcinoma in situ of the breast; second EORTC consensus meeting. Eur J Cancer 1992;28: 626-9.
7. Bur ME, Zimarowski MJ, Schnitt SJ, Baker S, Lew R. Estrogen receptor immunohistochemistry in carcinoma in situ of the breast. Cancer 1992;69:1174-81.
8. Bellamy COC, McDonald C, Salter DM, Chetty U, Anderson TJ. Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization. Hum Pathol 1993;24: 16-23.
9. Solin LJ, Yeh I-T, Kurtz J, et al. Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment. Cancer 1993;71:2532-42.
10. Poller DN, Roberts EC, Bell JA, Elston CW, Blarney RW, Ellis IO. p53 protein expression in mammary ductal carcinoma in situ: relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein. Hum Pathol 1993;24:463-8.
11. Leal CB, Schmitt FC, Bento MJ, Maia NC, Lopes CS. Ductal carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy, and immunohistochemical expression of hormone receptors, p53, and c-erbB-2 protein. Cancer 1995;75:2123-31.
12. Azzopardi JG. Epitheliosis and in situ carcinoma. In: Bennington JL, ed. Problems in breast pathology. Philadelphia: Saunders, 1979:128-46.
13. Rogers LW. Carcinoma in situ (CIS). In: Page DL, Anderson TJ, eds. Diagnostic histopathology of the breast. Edinburgh: Churchill Livingstone, 1987:157-92.
14. Lennington WJ, Jensen RA, Dalton LW, Page DL. Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions. Cancer 1994;73:118-24.
15. Holland R, Peterse JL, Millis RR, Eusebi V, Faverly D, van de Vijver MJ, et al. Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Path 1994;11:167-80.
16. Poller DN, Silverstein MJ, Galea M, et al. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification. Association between cellular proliferation and c-erbB-2 protein expression. Mod Pathol 1994; 7:257-62.
17. Silverstein MJ, Poller DN, Waisman JR, Colburn WJ, Barth A, Gierson ED, et al. Prognostic classification of breast ductal carcinoma in situ. Lancet 1995;345:1154-7.
18. Bobrow LG, Happerfield LC, Gregory WM, Millis RR. Ductal carcinoma in situ: assessment of necrosis and nuclear morphology and their association with biological markers. J Pathol 1995;176:333-41.
19. Bobrow LG, Happerfield LC, Gregory WM, Springall RD, Millis RR. The classification of ductal carcinoma in situ and its association with biological markers. Semin Diagn Pathol 1994;11:199-207.
20. Lampejo OT, Barnes DM, Smith P, Millis RR. Evaluation of infiltrating ductal carcinomas with a DCIS component: correlation of the histologic type of the in situ component with grade of the infiltrating component. Semin Diagn Pathol 1994;11:215-22,
21. Harrison M, Coyne JD, Gorey T, Dervan PA. Comparison of cytomorphological and architectural heterogeneity in mammographically detected ductal carcinoma in situ. Histopathology 1996;28:445-50.
22. Ottesen GL, Graversen HP, Blichert-Toft M, Zedeler K, Andersen JA. Ductal carcinoma of the female breast. Short term results of a prospective nationwide study. Am J Surg Pathol 1992;16:1183-96.